The semaphorin-3A (SEMA3A) point mutant isoform displays stronger activity on the inhibition of endothelial cells (ECs) in PC models due to its high affinity to bind Plexin A4 (PLXNA4) compared with its wild-type counterpart. The gene discussed is SEMA3A; the disease is pachyonychia congenita.